EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 254 filers reported holding EXELIXIS INC in Q2 2017. The put-call ratio across all filers is 1.05 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $106,000 | +92.7% | 4,486 | +44.7% | 0.03% | +172.7% |
| Q4 2019 | $55,000 | -94.1% | 3,100 | -92.1% | 0.01% | -91.1% |
| Q1 2019 | $928,000 | +1074.7% | 39,252 | +772.3% | 0.12% | +726.7% |
| Q3 2018 | $79,000 | +29.5% | 4,500 | +55.2% | 0.02% | +7.1% |
| Q2 2018 | $61,000 | -84.9% | 2,900 | -83.9% | 0.01% | -85.9% |
| Q1 2018 | $403,000 | +560.7% | 18,030 | +792.6% | 0.10% | +607.1% |
| Q4 2017 | $61,000 | -97.1% | 2,020 | -97.9% | 0.01% | -94.3% |
| Q1 2017 | $2,117,000 | +210.0% | 97,700 | +113.3% | 0.24% | +183.7% |
| Q4 2016 | $683,000 | -35.9% | 45,800 | -45.1% | 0.09% | -37.2% |
| Q3 2016 | $1,066,000 | +162.6% | 83,363 | -17.8% | 0.14% | +191.5% |
| Q1 2016 | $406,000 | – | 101,400 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 11,275,871 | $254,722,000 | 71.55% |
| GREAT POINT PARTNERS LLC | 1,201,100 | $27,133,000 | 5.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 886,534 | $20,027,000 | 5.30% |
| Sargent Investment Group, LLC | 498,350 | $11,258,000 | 2.96% |
| CAPITAL MANAGEMENT CORP /VA | 311,660 | $7,040,000 | 1.57% |
| EULAV Asset Management | 2,460,000 | $55,571,000 | 1.49% |
| CM Management, LLC | 80,000 | $1,807,000 | 1.34% |
| Integral Health Asset Management, LLC | 200,000 | $4,518,000 | 1.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,750,000 | $242,843,000 | 1.21% |
| Sofinnova Investments, Inc. | 839,181 | $18,957,000 | 1.14% |